453 related articles for article (PubMed ID: 25479074)
21. What precedes development of rheumatoid arthritis?
Klareskog L; Alfredsson L; Rantapää-Dahlqvist S; Berglin E; Stolt P; Padyukov L
Ann Rheum Dis; 2004 Nov; 63 Suppl 2(Suppl 2):ii28-ii31. PubMed ID: 15479868
[TBL] [Abstract][Full Text] [Related]
22. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).
Furst DE; Schiff MH; Fleischmann RM; Strand V; Birbara CA; Compagnone D; Fischkoff SA; Chartash EK
J Rheumatol; 2003 Dec; 30(12):2563-71. PubMed ID: 14719195
[TBL] [Abstract][Full Text] [Related]
23. Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up.
Dewedar AM; Shalaby MA; Al-Homaid S; Mahfouz AM; Shams OA; Fathy A
Int J Rheum Dis; 2012 Jun; 15(3):330-5. PubMed ID: 22709496
[TBL] [Abstract][Full Text] [Related]
24. Gene-environmental interaction between smoking and shared epitope on the development of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: a meta-analysis.
Lee YH; Bae SC; Song GG
Int J Rheum Dis; 2014 Jun; 17(5):528-35. PubMed ID: 24618101
[TBL] [Abstract][Full Text] [Related]
25. Use of leflunomide plus TNF-α inhibitors in rheumatoid arthritis.
Murdaca G; Spanò F; Puppo F
Expert Opin Drug Saf; 2013 Nov; 12(6):801-4. PubMed ID: 23889669
[TBL] [Abstract][Full Text] [Related]
26. The effect of anti-TNF-α vs. DMARDs on fatigue in rheumatoid arthritis patients.
van Hoogmoed D; Fransen J; Repping-Wuts H; Spee L; Bleijenberg G; van Riel PL
Scand J Rheumatol; 2013; 42(1):15-9. PubMed ID: 22992002
[TBL] [Abstract][Full Text] [Related]
27. Gene expression profiling of rheumatoid arthritis synovial cells treated with antirheumatic drugs.
Häupl T; Yahyawi M; Lübke C; Ringe J; Rohrlach T; Burmester GR; Sittinger M; Kaps C
J Biomol Screen; 2007 Apr; 12(3):328-40. PubMed ID: 17379860
[TBL] [Abstract][Full Text] [Related]
28. Risk factors for cardiovascular disease in rheumatoid arthritis.
Gabriel SE; Crowson CS
Curr Opin Rheumatol; 2012 Mar; 24(2):171-6. PubMed ID: 22249350
[TBL] [Abstract][Full Text] [Related]
29. Interaction between smoking, the shared epitope, and anti-cyclic citrullinated peptide: a mixed picture in three large North American rheumatoid arthritis cohorts.
Lee HS; Irigoyen P; Kern M; Lee A; Batliwalla F; Khalili H; Wolfe F; Lum RF; Massarotti E; Weisman M; Bombardier C; Karlson EW; Criswell LA; Vlietinck R; Gregersen PK
Arthritis Rheum; 2007 Jun; 56(6):1745-53. PubMed ID: 17530703
[TBL] [Abstract][Full Text] [Related]
30. Interactions between smoking, increased serum levels of anti-CCP antibodies, rheumatoid factors, and erosive joint disease in patients with early, untreated rheumatoid arthritis.
Krol A; Garred P; Heegaard NH; Christensen AF; Hetland ML; Stengaard-Pedersen K; Junker P; Madsen HO; Lottenburger T; Ellingsen T; Andersen LS; Hansen I; Pedersen JK; Svendsen AJ; Tarp U; Pødenphant J; Lindegaard H; Østergaard M; Hørslev-Petersen K; Jacobsen S
Scand J Rheumatol; 2015; 44(1):8-12. PubMed ID: 25205362
[TBL] [Abstract][Full Text] [Related]
31. Tobacco smoking and autoimmune rheumatic diseases.
Harel-Meir M; Sherer Y; Shoenfeld Y
Nat Clin Pract Rheumatol; 2007 Dec; 3(12):707-15. PubMed ID: 18037930
[TBL] [Abstract][Full Text] [Related]
32. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination.
Klareskog L; Stolt P; Lundberg K; Källberg H; Bengtsson C; Grunewald J; Rönnelid J; Harris HE; Ulfgren AK; Rantapää-Dahlqvist S; Eklund A; Padyukov L; Alfredsson L
Arthritis Rheum; 2006 Jan; 54(1):38-46. PubMed ID: 16385494
[TBL] [Abstract][Full Text] [Related]
33. Interaction between oxidative stress and smoking is associated with an increased risk of rheumatoid arthritis: a case-control study.
Navarro-Compán V; Melguizo-Madrid E; Hernández-Cruz B; Santos-Rey K; Leyva-Prado C; González-Martín C; Navarro-Sarabia F; González-Rodríguez C
Rheumatology (Oxford); 2013 Mar; 52(3):487-93. PubMed ID: 23148091
[TBL] [Abstract][Full Text] [Related]
34. Current tobacco smoking, formal education, and the risk of rheumatoid arthritis.
Uhlig T; Hagen KB; Kvien TK
J Rheumatol; 1999 Jan; 26(1):47-54. PubMed ID: 9918239
[TBL] [Abstract][Full Text] [Related]
35. Current concepts in clinical therapeutics: disease-modifying drugs for rheumatoid arthritis.
Pugh MC; Pugh CB
Clin Pharm; 1987 Jun; 6(6):475-91. PubMed ID: 3319362
[TBL] [Abstract][Full Text] [Related]
36. Influence of cigarette smoking on disease outcome in rheumatoid arthritis.
Harrison BJ
Curr Opin Rheumatol; 2002 Mar; 14(2):93-7. PubMed ID: 11845011
[TBL] [Abstract][Full Text] [Related]
37. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy.
Mäki-Petäjä KM; Hall FC; Booth AD; Wallace SM; Yasmin ; Bearcroft PW; Harish S; Furlong A; McEniery CM; Brown J; Wilkinson IB
Circulation; 2006 Sep; 114(11):1185-92. PubMed ID: 16952987
[TBL] [Abstract][Full Text] [Related]
38. Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries.
Chatzidionysiou K; Lie E; Nasonov E; Lukina G; Hetland ML; Tarp U; Gabay C; van Riel PL; Nordström DC; Gomez-Reino J; Pavelka K; Tomsic M; Kvien TK; van Vollenhoven RF
Ann Rheum Dis; 2011 Sep; 70(9):1575-80. PubMed ID: 21571731
[TBL] [Abstract][Full Text] [Related]
39. [Rheumatoid arthritis, inflammation, and atherosclerosis].
Hürlimann D; Enseleit F; Ruschitzka F
Herz; 2004 Dec; 29(8):760-8. PubMed ID: 15599672
[TBL] [Abstract][Full Text] [Related]
40. Smoking at onset of rheumatoid arthritis (RA) and its effect on disease activity and functional status: experiences from BARFOT, a long-term observational study on early RA.
Söderlin MK; Petersson IF; Bergman S; Svensson B;
Scand J Rheumatol; 2011; 40(4):249-55. PubMed ID: 21338325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
